T

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Associate Medical Director - Renal Cancer Theranostics

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • An advanced degree (PhD, PharmD, or MD) with renal oncology experience, or equivalent experience.
  • At least 8 years of Medical Affairs experience, including leading cross-functional initiatives in oncology or specialty therapeutics.
  • Experience working with clinical operations, research and development, and/or medical affairs.
  • Experience interpreting scientific data, market research, competitive intelligence, clinical utility evidence, and evolving clinical practice dynamics; proficiency in Microsoft Office Suite.
  • Ability to contribute to medical strategy and lead cross-functional execution in a matrixed environment.
  • Ability to interact externally and internally to support overall company business strategy.
  • Knowledge of clinical trial methodology and regulatory requirements governing clinical trials, and experience in development strategy and protocol design.
  • Ability to collaborate effectively across matrixed teams and influence without direct reporting authority.
  • Verbal, written, and presentation communication skills, including developing medical content for scientific exchange, speaker preparation, and podium presentations.
  • Ability to develop and execute medical affairs tactical plans incorporating lifecycle planning, competitive positioning, clinical utility, investigator-initiated trials, and clinical trial recruitment support.
  • Knowledge of regulations and compliance practices related to industry interactions with healthcare professionals.
  • Experience building relationships with key opinion leaders, investigators, and professional societies in oncology.
  • A valid driver’s license.

Responsibilities

  • Lead execution of the US medical affairs plan for the renal cancer theranostic portfolio, contributing to medical strategy, priorities, and the medical operating plan in partnership with the VP of Medical Affairs Americas.
  • Drive cross-functional alignment with US Medical Affairs, Clinical Development, Commercial, Market Access, Health Economics and Outcomes Research, Regulatory, Marketing, and Medical Information on medical deliverables and timelines.
  • Contribute to medical affairs strategy for renal cancer theranostic assets, including launch readiness and lifecycle planning, and lead integration of medical tactics and deliverables.
  • Serve as a subject-matter expert on renal cancer theranostics, providing scientific input into integrated medical planning, evidence gaps, and competitive landscape.
  • Provide medical leadership on renal cancer clinical protocol review, including recruitment strategy, data interpretation, investigator engagement, expanded access programs, clinical registries, and investigator-initiated trial protocol review.
  • Develop and review scientifically accurate medical content, including podium presentation materials, speaker decks, medical education programs, advisory board content, symposia materials, and promotional and non-promotional resources through medical, legal, and regulatory review.
  • Prepare and support internal and external speakers, ensuring scientific narrative, clinical context, competitive landscape, and use of data are clear, balanced, compliant, and aligned to medical strategy.
  • Build and maintain scientific relationships with key opinion leaders, investigators, and professional societies in renal cancer theranostics.
  • Maintain current knowledge of renal cancer radiopharmaceutical publications, clinical trials, treatment guidelines, patient journey dynamics, and competitive data, and translate implications into recommendations for medical leadership.

Desired Qualifications

  • Deep expertise in renal cancer radiopharmaceuticals, theranostics, imaging and therapy integration, and the renal cancer patient journey.

About the Company

Telix Pharmaceuticals

Develops targeted radiation diagnostics and therapies

Telix Pharmaceuticals develops and commercializes diagnostic and therapeutic products that use targeted radiation to diagnose and treat cancer and rare diseases. Its pipeline covers urologic oncology (prostate and kidney cancers), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. The treatments work by delivering targeted radiation to diseased tissues, enabling more precise decisions for treatment and allowing for personalized therapy. The company differentiates itself through a global, robust supply chain and a focus on integrating diagnostic and therapeutic options to address unmet medical needs, along with strong commitments to patient care, ethical practices, and environmental responsibility. Telix’s goal is to improve quality of life and outcomes for patients by providing targeted, clinically meaningful diagnostic and therapeutic solutions that support better treatment decisions and personalized care.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Melbourne VIC, Australia
Founded
2015

Recently Posted Jobs

Explore more opportunities at Telix Pharmaceuticals

See more jobs